Table 1. Clinicopathologic features and plasma level of HIF-1α.
| Category | No. of cases | plasma level of HIF-1α Mean± SD | Statistics value | P value |
|---|---|---|---|---|
| Age | ||||
| ≤55 | 131 | 10.150±1.713 | t =0.423 | 0.672 |
| >55 | 136 | 10.242±1.817 | ||
| Tumor size | ||||
| ≤2cm | 164 | 9.698±1.795 | t'= −6.599 | 0.001 |
| >2cm | 103 | 10.991±1.391 | ||
| Skin involvementa | ||||
| No | 227 | 10.040±1.751 | t = −3.532 | 0.001 |
| Yes | 40 | 11.086±1.585 | ||
| LN metastasisb | ||||
| No | 169 | 9.728±1.675 | F=14.853 | 0.001 |
| 1~3 | 49 | 11.079±1.387 | ||
| 4~9 | 27 | 11.079±1.557 | ||
| 10~ | 13 | 11.431±1.696 | ||
| Unknown | 9 | |||
| Histologic grade | ||||
| ≤II | 206 | 10.167±1.812 | t'= −1.895 | 0.061 |
| >II | 50 | 10.591±1.306 | ||
| Unknown | 11 | |||
| Hormone receptor | ||||
| (−) | 66 | 10.271±1.555 | t = 0.274 | 0.785 |
| (+) | 188 | 10.201±1.859 | ||
| Unknown | 13 | |||
| HER-2 | ||||
| (−~+) | 116 | 10.165±1.823 | t= −0.758 | 0.450 |
| (++~+++) | 113 | 10.341±1.704 | ||
| Unknown | 38 | |||
| Tumor typec | ||||
| DCISd | 26 | 8.646±2.101 | Chi-Square =14.833 | 0.002 |
| IDCe | 224 | 10.380±1.636 | ||
| ILCf | 5 | 10.258±2.879 | ||
| OTHERg | 12 | 10.113±1.253 | ||
| Clinical stageh | ||||
| I | 115 | 9.275±1.797 | Chi-Square =43.153 | 0.001 |
| II | 83 | 10.729±1.221 | ||
| III | 69 | 11.092±1.540 | ||
| PGC-1α plasma leveli | ||||
| low | 134 | 9.745±1.853 | t'= −4.344 | 0.001 |
| high | 133 | 10.652±1.548 |
skin involvement includes: edema, redness, nodularity or ulceration of the skin
Post Hoc Multiple Comparisons(LSD) shows difference of HIF-1αconcentration only presence in the group without LN metastasis and the other groups
Post Hoc Multiple Comparisons(Games-Howell) shows difference of HIF-1αconcentration only presence in the DCIS group and the other groups
DCIS: ductal carcinoma in situ
IDC: invasive ductal carcinoma.
ILC: invasive lobular carcinoma
OTHER include: mucinous or colloid carcinoma, medullary carcinoma, metaplastic carcinoma.
Post Hoc Multiple Comparisons(Games-Howell) shows difference of HIF-1αconcentration only presence in the stage I group and the other groups
median of PGC-1α plasma level was 244.24 ng/dl